10.1523/jneurosci.15-05-04102.1995 117 TedfordH
Key Market Players: Glucagon-like Peptide-1 (GLP-1) Agonists Market Leaders Novo Nordisk Eli Lilly and Company AstraZeneca Sanofi Pfizer
Murillo-Cuesta S, Rodriguez-de la Rosa L, Cediel R, Lassaletta L, Varela-Nieto I: The role of insulin-like growth factor-I in the physiopathology of hearing
doi: 10.1016/j.ejphar.2011.11.005 150 ZhouMChenSPengPGuZYuJZhaoGet al
CrossRef Dietary Patterns, Cooking Methods, and Their Association with Prediabetes Risk Markers in Romanian University Students: A Cross-Sectional Analysis Teodora Piro, Raluca Lupusoru, Lavinia Cristina Moleriu, Clin Muntean, Radu Dumitru Moleriu, Dora Mihalea Cmpian, Mdlina Gabriela Cincu, Elena Gabriela Strete, Amalia Gabriela Timofte, Ruxandra-Cristina Marin Nutrients.2026
10 Safety of Liraglutide: Pancreatitis has rarely been experienced by patients taking liraglutide (7 cases in phase II and III trials of 4,257 patients), prompting the close monitoring of the development of pancreatitis in patients prescribed liraglutide